NCT03742063View on ClinicalTrials.gov

Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

October 30, 2018

Conditions
Clinical ResponseHistopathological ResponsePrognosis
Interventions
DRUG

first-line chemotherapy

patients who routinely received neoadjuvant chemotherapy according to Peking University People's Hospital chemo-protocols (PKUPH-OS and PKUPH-ES)

Trial Locations (2)

100044

Peking University People's Hospital, Beijing

Peking University Shougang Hospital, Beijing

All Listed Sponsors
collaborator

Peking University Shougang Hospital

OTHER

lead

Peking University People's Hospital

OTHER

NCT03742063 - Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in Bone | Biotech Hunter | Biotech Hunter